Rawojć, K.; Ahmed, M.M.; Mukhtiar, A.; Łukowiak, M.; Kisielewicz, K.
Nanomedicine-Enhanced Radiotherapy for Glioblastoma: Advances in Targeted Therapy and Adaptive Treatment Strategies. Pharmaceutics 2025, 17, 508.
https://doi.org/10.3390/pharmaceutics17040508
AMA Style
Rawojć K, Ahmed MM, Mukhtiar A, Łukowiak M, Kisielewicz K.
Nanomedicine-Enhanced Radiotherapy for Glioblastoma: Advances in Targeted Therapy and Adaptive Treatment Strategies. Pharmaceutics. 2025; 17(4):508.
https://doi.org/10.3390/pharmaceutics17040508
Chicago/Turabian Style
Rawojć, Kamila, Mansoor M. Ahmed, Ayesha Mukhtiar, Magdalena Łukowiak, and Kamil Kisielewicz.
2025. "Nanomedicine-Enhanced Radiotherapy for Glioblastoma: Advances in Targeted Therapy and Adaptive Treatment Strategies" Pharmaceutics 17, no. 4: 508.
https://doi.org/10.3390/pharmaceutics17040508
APA Style
Rawojć, K., Ahmed, M. M., Mukhtiar, A., Łukowiak, M., & Kisielewicz, K.
(2025). Nanomedicine-Enhanced Radiotherapy for Glioblastoma: Advances in Targeted Therapy and Adaptive Treatment Strategies. Pharmaceutics, 17(4), 508.
https://doi.org/10.3390/pharmaceutics17040508